Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201101293468N5Phase 2Completed
Phase 2 trial of midazolam in amnesia, sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Sedation level and Amnesia effect. Started Apr 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201101293468N5.